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Background: The emerged human infection with avian influenza A (H7N9) virus in China since 2013 has aroused
global concerns. There is great demand for simple and rapid diagnostic method for early detection of H7N9 to
provide timely treatment and disease control. The aim of the current study was to develop a rapid, accurate and
feasible reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for detection of H7N9 virus.
Results: The detection limits of the H7- and N9-specific RT-LAMP assay were both approximately 0.2 PFU per reaction.
No cross-reactivity was observed with other subtype of influenza viruses or common respiratory viral pathogens. The
assay worked well with clinical specimens from patients and chickens, and exhibited high specificity and sensitivity.
Conclusions: The H7/N9 specific RT-LAMP assay was sensitive and accurate, which could be a useful alternative in clinical
diagnostics of influenza A (H7N9) virus, especially in the hospitals and laboratories without sophisticated diagnostic systems.
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Since February 2013,a novel avian influenza A (H7N9)
virus has emerged in China, resulting in human infections
[1]. As of 7 Sept 2014, the Chinese CDC reported 452
laboratory-confirmed human cases [2]. According to the
etiology and gene traceable results, H7N9 avian flu virus is
a new recombinant virus [3-5]. Human infection with avian
influenza A (H7N9) virus usually results in an influenza-
like illness (ILI) with symptoms such as fever, cough with
little to no sputum production, accompanied by headache,
muscular soreness, and general malaise [6]. Most patients
presented with rapidly progressing severe lower respiratory
tract infections. Considering that the novel avian H7N9 is
characteristic of mammalian adapted, scientific community* Correspondence: Jiang_tao@126.com; qincf@bmi.ac.cn
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could cause a new influenza pandemic [7,8].
Several newly published researches indicated that the
H7N9 virus exhibited human-type receptor-binding ability
and could replicate in mammals [9-11]. H7N9 virus could
invade epithelial cells in human lower respiratory tract
and pneumonocytes [11]. These biological characteriza-
tions of H7N9 virus increase the pandemic risk espe-
cially that the virus acquires the ability of transmitting
readily among humans, and the lack of pre-existing im-
munity to virus of this subtype among humans [12]. There-
fore, the risk of a pandemic caused by avian H7N9 virus
requires rapid detection methods.
Currently, the available detection methods for H7N9
virus include virus isolation and real-time RT-PCR assay
[6]. The serological detection and real-time PCR were
recommended to detect avian influenza A (H7N9) in 2013
by World Health Organizatin (WHO) [13]. ConsideringThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tors of real-time RT-PCR assay, there is great demand for
simple, rapid and sensitive diagnosis method for early
detection of H7N9 to provide timely treatment and dis-
ease control. The loop-mediated isothermal amplifica-
tion (LAMP) method, first described in 2000, has been
proved to be a rapid, accurate, and cost-effective diag-
nostic method for infectious diseases [14-16]. Previously,
the LAMP methods have been applied for detection of dif-
ferent subtypes of influenza viruses, including avian H3,
H5, H7, H9, the 2009 H1N1 influenza virus, seasons type A
or B influenza virus, and H3 swine influenza virus [17-23].
All these assays showed high specificity, efficiency, and sen-
sitivity that were similar to or even higher than real-time
PCR assays. These studies exhibited the potential of LAMP
as a routine diagnostic method for influenza infections.
In this study, a H7N9-specific RT-LAMP assay target-
ing the HA or NA gene of avian influenza A (H7N9)
virus was developed and evaluated with clinical throat
swab and avian samples. The results demonstrated that
the RT-LAMP assay was sensitive and accurate, which
could be a useful alternative in clinical diagnostics of
influenza A (H7N9) virus, especially in the hospitals and
laboratories without sophisticated diagnostic systems.
Results
The primer sets of H7 or N9 specific RT-LAMP com-
prise two outer primers (F3 and B3), two inner primers
(FIP and BIP), and one loop primer LF that recognize seven
distinct regions on the target sequence of HA or NA gene.
Considering that the genomic stability of the emerging
reassorted H7N9 was still unclear, the target sequences
of the primers were optimized to avoid covering the hot
spot in HA or NA gene, such as receptor binding domain
or membrane fusion loop in HA gene. After evaluation
with different dilutions of H7N9 viral RNA, the primer




H7FIPb (1398-1419) + (1356-1375) 44




N9FIP (1115-1138) + (1076-1091) 44
N9BIP (1146-1168) + (1201-1221) 44
N9LF 1092-1113 22
aH7N9 strain A/Anhui/1/2013 [GISAID: EPI439507 & EPI439509].
bFIP and BIP primer are long primers containing two separate recognition sequenceThe detection limits of the H7 and N9 specific RT-
LAMP assay were both 0.2 PFU per reaction (Figure 1A
and C), which was 10-fold-higher sensitive than that of
real-time RT-PCR assay recommended by WHO (Table 2).
Furthermore, the cross-reactivity tests with seven respira-
tory viruses also revealed the high specificity of the H7/N9
RT-LAMP assay.
Discussion
The RT-LAMP assay could finish within 45 minutes. By
using fluorescent detection reagent, the positive amplifica-
tion could be observed by color change. As shown in the
Figure 1B and D, the color of positive reaction (H7N9)
change from orange to green under natural light, while the
positive reaction also produced bright green fluorescence
under UV light. For negative sample such as H1N1, H3N2,
H5N1, PIV3, H9N2, RSV and HAdV-3 virus, the color of
reaction mixture did not change either under normal light
or under UV light.
The H7/N9-specific RT-LAMP assay was further evalu-
ated using clinical samples and chicken samples compared
with rRT-PCR assay. The RT-LAMP results showed that
17 samples were tested to be positive and the other 10
samples were negative for H7N9, respectively, which could
be confirmed by rRT-PCR assay. No false positive and
false negative were observed. By using these 27 samples,
100% diagnostic sensitivities were achieved with H7 or N9
specific RT-LAMP assay compared with rRT-PCR assays,
which showed that RT-LAMP results were consistent with
that of rRT-PCR. The LAMP method aimed to detect
2013 avian influenza H7N9 showed reliable results in the
detection of avian and human clinical samples.
Previously, two RT-LAMP systems had been developed
for detection of avian influenza subtype H7 virus [17,23].
Currently, some other RT-LAMP assays for detection of
H7N9 virus were also developed [24-28]. These assays












s with a TTTT linker (italics).
Figure 1 Sensitivity and specificity of the H7/N9 -specific RT-LAMP assay. Amplification curves of the H7/N9-special RT-LAMP were performed
with 10-fold serial dilutions of viral RNA (from 200 to 0.002 PFU per reaction). Specificities of H7 and N9 RT-LAMP were tested by using direct visual
detection of RT-LAMP with RNA extracted from viral culture of H1N1, H3N2, H5N1, PIV3, H9N2, RSV, HAdV-3 and H7N9. (A) Detection limit of H7-specific
RT-LAMP was 0.2 PFU per reaction. (B) The color changes under natural or UV light were only observed in the tube of H7N9 viral RNA by using
H7-specific RT-LAMP assay. (C) Detection Limit of N9-specific RT-LAMP was 0.2 PFU per reaction. (D) The color changes were observed for
N9-specific RT-LAMP reaction with H7N9 viral RNA. No color change was seen in RT-LAMP with other subtype of influenza viral RNA and other
three respiratory viruses under natural or UV light.
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RT-LAMP methods, were very useful for the early detection
of suspected H7N9 infection, and could contribute to the
prevention and control of H7N9 epidemics and potential
pandemic in China and other asian countries.
Conclusions
The current study described a rapid, accurate and feasible
H7/N9 specific RT-LAMP assay with perfect sensitivities
and high specificities. It was simple and easy to perform.
This assay have the potential to provide useful toolsTable 2 Comparison of detection of H7N9 virus by using RT-L
Strain Virus Titer (PFU/reaction) rRT-PCR(H7)(Ct)






aND, not detectable.for detection of novel H7N9 virus especially in resource-
limited setting, which will play important roles in the pre-
vention and control of spread of novel H7N9 infection.
Methods
Samples
A total of 5 clinical throat-swab samples were collected
from suspected patients with H7N9 infection. All samples
were collected between 2 days and 7 days after the onset
of illness. The clinical samples used in this study were
appropriately anonymized. All individuals participatingAMP and rRT-PCR assay
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approval was obtained and guidelines were followed for
the use of clinical material and accession to diagnostic
results. A total of 22 mixed chicken stool samples were
collected randomly from live poultry market in Nanjing,
Jiangsu and got permission by the chicken farmer and
administrator of poultry market. The stool samples were
added by phosphate-buffered saline (PBS; 0.02 mol/L;
pH 7.2) to make a 10% stool suspension and then cen-
trifuged at 13,000 g for 5 min. The suspension was sub-
sequently processed for RNA extraction.
The collection of samples for the present study was ap-
proved by the Ethical Committee of the State Key Labora-
tory of Pathogen and Biosecurity (Beijing, China), and the
experimental procedures were carried out in strict accord-
ance with guidelines on animal ethics and welfare.Viruses
The H7N9 virus strain A/Anhui/1/2013, kindly provided
by Chinese national influenza center (CNIC), was used as
reference virus in the current study. Seven respiratory vi-
ruses, including human influenza virus H1N1 virus strain
A/California/07/2009, H3N2 virus strain A/Beijing/073103/
2009, H5N1 virus strain A/Vietnam/1194/2004, avian H9N2
virus strain A/chicken/Nanjing/1/2013, and other important
respiratory viruses including type 3 parainfluenza virus
(PIV3) strain BJ/01/2005, respiratory syncytial virus (RSV)
strain BJ/01/2004 and human adenovirus type 3 (HAdV-
3) strain GB, were used to evaluate the specificity of the
assay.Primers design of RT-LAMP
The nucleotide sequences of complete genome of H7N9
strains were retrieved from the GenBank and GISAID
(Global Initiative on Sharing All Influenza Data), and
aligned by using the ClustalX multiple sequence alignment
program. The RT-LAMP assay primers were designed on
the basis of the H7N9 HA or NA alignments by using
the LAMP primer designing software PrimerExplorer
(http://primerxplorer.jp/e/). The feasibility of all sets of
primers was then subsequently validated by BLAST program
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and ClustalW soft-
ware [29]. The primers were synthesized by Life Tech-
nologies (Shanghai) Ltd.RNA extraction
Total RNA was extracted from 200 μl of the clinical sam-
ples or viral culture supernatant by using the RNeasy®
Mini Kit (Qiagen, Hilden, Germany) according to the in-
structions of the manufacturer. The RNA was eluted in a
final volume of 50 μl of RNase-free water and stored at
-80°C until used.RT-LAMP
The RT-LAMP reaction was carried out by using the
Loopamp RNA amplification kit (Eiken Chemical, Tokyo,
Japan). The reaction system contained 5 μl of total RNA,
40 pmol each of the primers FIP and BIP, 5 pmol each of
the outer primers F3 and B3, 20 pmol of LF, 12.5 μl of 2 ×
Reaction Mix, 1 μl of Enzyme Mix and 1 μl of Fluorescent
regent. The reaction mixture was incubated at 63°C for
45 min in a Loopamp real-time turbidimeter LA-320
(Eiken Chemical, Tokyo, Japan) and followed by heating
at 80°C for 5 min to terminate the reaction. The optical
density data of each reaction was real-time recorded every
6 s. The threshold of the turbidity for positive sample was
defined at 0.1. The time of positivity (Tp) was determined
when the turbidity value increased above the threshold.
Real-time RT-PCR
As compared with the RT-LAMP detection, real-time
RT-PCR (rRT-PCR) was carried out with the set of specific
primers and probe for the detections of influenza A H7N9
virus recommended by WHO. The rRT-PCR was per-
formed with the One-Step PrimeScript™ RT-PCR Kit
(Takara, Dalian, China) in the LightCycler 2.0 system
(Roche, Mannheim, Germany) in a 20 μl mixture con-
taining 2 μl of total RNA, 10 μl of 2 ×One Step RT-PCR
Buffer III, 0.4 μl of Ex Taq, 0.4 μl of PrimeScript™ RT En-
zyme Mix II, 0.8 μM of forward primer, 0.8 μM of reverse
primer and 0.8 μM of probe. The reaction was performed
for 5 min at 42°C, followed by 20 s at 95°C, with a subse-
quent 40 cycles of amplification (95°C for 5 s, 55°C for
20 s). Fluorescence was recorded at 55°C.
Sensitivity and specificity of the assays
The sensitivities of the RT-LAMP assay and rRT-PCR
assay were analyzed using 10-fold serially dilutions of
viral RNA. The H7N9 virus strain A/Anhui/1/2013 was
used to evaluate the sensitivity of RT-LAMP assay de-
veloped in the current study. The concentrations of viral
RNA were serial diluted from 200 PFU to 0.002 PFU per
reaction, respectively. The specificity of the assay was evalu-
ated by cross-reactivity tests with seven respiratory viruses,
including human influenza H1N1 virus, H3N2 virus, H5N1
virus, avian H9N2 virus, PIV3, RSV and HAdV-3.
Evaluation with clinical samples
The H7/N9-specific RT-LAMP assay was evaluated using
clinical samples from suspected patients with H7N9 infec-
tion and chicken stool samples collected from local live
poultry markets. A total of 27 samples were tested for the
presence of H7N9 virus by using the RT-LAMP assay and
the real-time RT-PCR assay. Cp value of rRT-PCR less
than 35 was judged as positive. Positive standard was iden-
tified as emergence of the positive curve or the color
change within 45 minutes in the RT-LAMP assay.
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